Covifenz

The federal government isn't considering putting up money to help buy shares in the only domestic manufacturer of COVID-19 vaccines, but it is "working on a solution" with Medicago's parent company.

Canada may not be able to donate millions of doses of the only COVID-19 vaccine made in the country because the World Health Organization is leaning against granting it an emergency-use licence.

Known as Covifenz, the vaccine was developed by Medicago, a biotechnology company based in Quebec City that uses a plant host to make virus−like particles which help the body’s immune system make antibodies.